Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial

K. Gowin, T. Jain, H. Kosiorek, R. Tibes, J. Camoriano, J. Palmer, R. Mesa

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences